Search

everythinglearnresearchcommunity

for

Search:↓

Paljeong-san pharmacopuncture helps reduce symptoms of enlarged prostate by slowing tissue growth.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Dutasteride effectively treats enlarged prostate with manageable side effects.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Finasteride reduces prostate size and symptoms with few side effects.

Finasteride improves prostate cancer detection in PSA test.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

The document concludes that better training and education are needed for proper cancer screening and criticizes the GMC's inaction as harmful to clinical ethics in the UK.

Women with congenital adrenal hyperplasia showed no prostatic growth.

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Large prostates link to more hair loss.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Serum triglyceride levels are not linked to prostate cancer risk.